Yahoo Web Search

Search results

1. • 

     Nail Psoriasis

     Health via Yahoo News· 7 days ago

     In moderate cases of nail psoriasis, your provider may recommend steroid injections under the nail or laser treatments to help improve your symptoms....

2. • 

     Finding the Best Psoriasis Treatment: How I Got Psoriasis Relief

     Verywell Health via Yahoo News· 2 days ago

     Takeaway Humira was one of the first biologic medications approved for psoriatic arthritis in 2005...

3. • 

     6 Signs of an Autoimmune Disease That Can Be Easy to Miss

     Self via Yahoo News· 6 days ago

     Actor Jamie-Lynn Sigler, who has been open about living with the condition, used to have symptoms so...

4. • UCB Announces Publication in The Lancet of Phase 3 BIMZELX® (bimekizumab-bkzx) Trials in...

     KTLA-TV Los Angeles· 15 hours ago

     In these studies, bimekizumab consistently demonstrated sustained improvements in clinical- as well as patient...

5. • 

     Treatment for Adult Diaper Rash

     Verywell Health via Yahoo News· 5 days ago

     The signs of a severe diaper rash or a mild rash that is getting worse include: Significant redness or discoloration, warm to the touch Raw...possible...

6. • Ultravate side effects: What they are and how to manage them

     Healthline· 4 days ago

     Ultravate (halobetasol propionate) is a prescription drug that’s used to treat plaque psoriasis. Ultravate can cause side effects that range from mild to serious. Specifically ...

7. • 

     How Long Does Carpal Tunnel Syndrome Usually Last? A Review By Doctors

     MSN News· 5 days ago

     Expert opinion from Marcelle Freire Doctor of Medicine · 3 years of experience · Brazil Carpal...

8. • 

     What to do about rashes on skin

     Rolling Out· 6 days ago

     Rashes on the body can be both uncomfortable and concerning, affecting people of all ages and backgrounds. These skin irritations may range from mild

9. • Teva and Alvotech Announce SIMLANDI® (adalimumab-ryvk) Injection Now Available in the U.S.

     Morningstar· 3 days ago

     “We are proud to make SIMLANDI available in the U.S. to patients and providers,” said Thomas Rainey, Senior Vice President, U.S. Market...

10. • TREMFYA® (guselkumab) QUASAR Maintenance Study in UC met its primary endpoint and all major...

      FOX 23 News Albany· 4 days ago

      ...20, 2024 /PRNewswire/ -- Johnson & Johnson today announced the first data from the Phase 3 QUASAR Maintenance Study (Abstract #759) that showed 50.0 percent (p<0.001) of patients with moderately to severely active ulcerative colitisa (UC) receiving subcutaneous (SC) TREMFYA® (guselkumab) 200 mg...